Room A260 300 Pasteur Drive
Stanford, CA 94305
Stanford Heart Failure & Cardiomyopathy
Many years of research at Stanford have led to precise diagnoses and promising new treatments for patients with congestive heart failure and cardiomyopathy. Our multidisciplinary team strives to create the best possible treatment plan for each patient. We offer:
- A comprehensive range of care, including medical management, device implantation, and heart transplantation
- Advanced diagnostic and treatment options, including left ventricular assist device (LVAD) therapy for both short-term and long-term use
- The benefit of cutting-edge research, including new approaches to diagnosing cardiomyopathy using genetic testing and new therapies for improving the lives of patients
- Specialized programs within heart failure, including amyloid heart disease, hypertrophic cardiomyopathy, inherited cardiovascular disease, and chemotherapy/radiation induced heart disease
Your Health with Dipanjan Banerjee, MD |
Patient Stories |
|
Stanford cardiologist, Dipanjan Banerjee, MD, discusses Left Ventricular Assist Device (LVAD). LVAD was originally used as a bridge-to-transplant device, but patients have been doing so well, the need for a heart transplant may be reduced among this patient population. |
James Cooper shares his success story dealing with hypertrophic cardiomyopathy. Patient Donna Jackson's life was saved by the left ventricular assist device (LVAD). |



















